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vaccine effectiveness is 92% for persons who received 1 
dose and 95% for those who received 2 doses (9). As-
suming that vaccine effectiveness is lower shifts the curve 
(Figure) to the left and would result in a lower estimate of 
vaccination coverage. Second, different numbers of per-
sons who received 1 and 2 doses complicate the identifi-
cation of overall vaccine effectiveness. Third, vaccination 
status is unknown for some measles case-patients. The 
proportion of nonvaccinated persons among those case-
patients might be higher than that among those known to 
be vaccinated, also leading to a lower estimate of vac-
cination coverage. Finally, nonvaccinated persons might 
be clustered together, and their risk for infection could 
be higher than that for the general population (10). This 
scenario would imply that the estimated vaccination cov-
erage does not reflect the general population but instead 
corresponds to a clustered subpopulation among whom 
vaccination rates are lower. The effects of these com-
plexities warrant further investigation. However, as the 
examples demonstrate, a model ignoring those effects is 
in good agreement with empirical data.
Our analysis suggests that the number of vaccinated 
measles case-patients should be closely followed through 
surveillance programs. A continuous decrease in the pro-
portion of measles case-patients who had been vaccinated 
over the years could indicate a decrease in vaccination rates. 
Conversely, an increase in the proportion of measles case-
patients who had been vaccinated would demonstrate the ef-
fectiveness of ongoing efforts to increase vaccination rates 
and could serve as a benchmark toward measles elimination.
C.L.A. received funding through an Ambizione grant from the 
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To the Editor: Lassa fever is a zoonosis caused by 
Lassa virus (LASV; family Arenaviridae, genus Lassavi-
rus). The primary reservoir of LASV is the multimammate 
rat (Mastomys natalensis), which is found throughout sub-
Saharan Africa. LASV outbreaks among humans occur 
only in West Africa in 2 noncontiguous areas: 1 in Guinea, 
Liberia, and Sierra Leone; and 1 in Nigeria. Rare cases and 
evidence of exposure of humans have been documented 
in neighboring countries (i.e., Benin, Burkina Faso, Côte 
d’Ivoire, Ghana, Mali, and Togo) (1). LASV RNA has been 
detected in only 4 patients: 1 in Germany who had trav-
eled in Burkina Faso, Côte d’Ivoire, and Ghana (2); 1 in the 
United Kingdom who had returned from Mali (3); and 2 in 
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Ghana, for whom no viral sequence was available because 
detection was performed by reverse transcription PCR only 
(4). In the region in Mali where the patient from the United 
Kingdom was infected, identical LASV sequences were 
found in multimammate rats (5). The sequence of the strain 
identified from the patient in Germany, who was designat-
ed AV, is the closest known relative of the clade formed 
by sequences from Mali (5). However, LASV was not 
found in its natural host in any of the countries visited by 
patient AV (6,7).
For a study investigating zoonotic pathogens in rural 
habitats, we caught small mammals in 3 ecologic zones of 
Côte d’Ivoire: 1) dry bushland in northern Côte d’Ivoire, 
around Korhogo (2); semiarid bushland in central Côte 
d’Ivoire, around Bouake; and rainforest in southwest-
ern Côte d’Ivoire, near the Taï National Park (3) (online 
Technical Appendix Figure, http://wwwnc.cdc.gov/EID/
article/21/8/15-0312-Techapp.pdf). Traps were installed 
within and around 15 villages and enabled the capture of 
27 eulipotyphlans and 254 rodents during August–October 
2013. Animals were assigned at the genus level in the field 
on the basis of morphology. For 88% of them, assignment 
could later be refined to the species level by sequencing a 
fragment of the mitochondrial cytochrome b gene. A total 
of 14 animal species representing 8 genera were detected. 
All host sequences were deposited in Dryad (http://www.
datadryad.org/; online Technical Appendix Table 1). Mul-
timammate rats were the dominant commensals at all sam-
pling locations, comprising 64.5% of the overall sample 
(online Technical Appendix Figure).
Tissue samples were collected from all animals accord-
ing to standard protocols. Total nucleic acids were extract-
ed from lung samples and tested for the presence of LASV 
RNA by using a real-time PCR system amplifying a 400-bp 
fragment of the large genomic segment (8)  (online Technical 
Appendix). LASV RNA was detected in 4 of 18 specimens 
of M. natalensis captured in Gbalôhô, near Korhogo (on-
line Technical Appendix Figure). This site is much farther 
north in Côte d’Ivoire than previously examined sites (6). 
The 4 PCR-positive animals were 3 males and 1 female 
that were all captured indoors, 3 in the same house. PCR 
products were sequenced according to the Sanger method 
(GenBank accession nos. LN823982–LN823985). Ac-
cording to phylogenetic analyses performed in maximum 
likelihood and Bayesian frameworks (online Technical Ap-
pendix), LASV sequences identified in multimammate rats 
from Côte d’Ivoire formed a robust clade with sequences 
from the human AV strain and the LASV infecting mul-
timammate rats in southern Mali (bootstrap 97, posterior 
probability 1.00; Figure). This phylogenetic placement 
opens up the possibility that patient AV was infected dur-
ing her travel through Côte d’Ivoire, possibly in or near the 
city of Korhogo. Tip date calibration of Bayesian analyses 
showed that the most recent common ancestor of all LASV 
sequences from Côte d’Ivoire and Mali circulated ≈90 
years ago (Figure; online Technical Appendix Table 2).
Further studies will be needed to investigate the geo-
graphic distribution of LASV in Côte d’Ivoire and the fre-
quency of human infections. The current lack of diagnosed 
cases in the area may be caused by underreporting. Sensi-
tization campaigns are needed to increase awareness of the 
risk for LASV infection among the local population and to 
improve detection of cases by health workers.
Acknowledgments
We thank the Ministry of Health of Côte d’Ivoire and the directors 
of the Laboratoire National d’Appui au Développement Agricole 
and Centre Hospitalier Universitaire, Bouake, Côte d’Ivoire for 
their support and permission to conduct the study. We also thank 
the chiefs of the various villages where captures were performed 
1482 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 8, August 2015
LETTERS
Figure. Bayesian chronogram of Lassa virus (LASV) 
sequences determined on the basis of a fragment 
of the large genomic segment. Branches receiving 
posterior probability values <0.95 and bootstrap 
values <50 (poorly supported) are dashed. LASV 
sequences of human origin are indicated by ovals, 
and those of multimammate rats are indicated by 
squares. Sequences reported in this study are 
indicated by black squares. This tree was built under 
the assumption of a molecular clock and is therefore 
rooted. The numerical value on the tree’s most 
basal branch is the root posterior probability of this 
branch; it supports the notion that LASV sequences 
from Nigeria and other countries are not reciprocally 
monophyletic. GenBank accession nos. of sequences 
used for phylogenetic analyses are shown in online 
Technical Appendix Table 2 (http://wwwnc.cdc.gov/
EID/article/21/8/15-0312-Techapp.pdf). AV strain 
indicates the strain from a German patient.
for their permission and support; the Swiss Research Center, Côte 
d’Ivoire, for logistical support; A. Krou, Y. Djambra, B. Gragnon, 
F. Beudjé, and M. Coulibaly for technical support during field mis-
sions; and U. Thiesen, K. Merkel, A. Sachse, and the sequencing 
laboratory team of the Robert Koch Institute for laboratory support.
This work was funded by the Deutsche Forschungsgesellschaft 
grant LE1813/7-1.
References
  1. Sogoba N, Feldmann H, Safronetz D. Lassa fever in West Africa: 
evidence for an expanded region of endemicity. Zoonoses Public 
Health. 2012;59(Suppl 2):43–7. http://dx.doi.org/10.1111/ 
j.1863-2378.2012.01469.x
  2. Günther S, Emmerich P, Laue T, Kuhle O, Asper M, Jung A, et al. 
Imported lassa fever in Germany: molecular characterization of a 
new lassa virus strain. Emerg Infect Dis. 2000;6:466–76.  
http://dx.doi.org/10.3201/eid0605.000504
  3. Atkin S, Anaraki S, Gothard P, Walsh A, Brown D, Gopal R,  
et al. The first case of Lassa fever imported from Mali to the United 
Kingdom, February 2009. Euro Surveill. 2009;14: pii:19145.
  4. Dzotsi EK, Ohene SA, Asiedu-Bekoe F, Amankwa J, Sarkodie B, 
Adjabeng M, et al. The first cases of Lassa fever in Ghana. Ghana 
Med J. 2012;46:166–70.
  5. Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, Fischer ER, 
et al. Detection of Lassa virus, Mali. Emerg Infect Dis. 
2010;16:1123–6.
  6. Coulibaly-N’Golo D, Allali B, Kouassi SK, Fichet-Calvet E, 
Becker-Ziaja B, Rieger T, et al. Novel arenavirus sequences in 
Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d’Ivoire: 
implications for evolution of arenaviruses in Africa. PLoS ONE. 
2011;6:e20893. http://dx.doi.org/10.1371/journal.pone.0020893
  7. Kronmann KC, Nimo-Paintsil S, Guirguis F, Kronmann LC,  
Bonney K, Obiri-Danso K, et al. Two novel arenaviruses detected 
in pygmy mice, Ghana. Emerg Infect Dis. 2013;19:1832–5.  
http://dx.doi.org/10.3201/eid1911.121491
  8. Lecompte E, Fichet-Calvet E, Daffis S, Koulemou K, Sylla O, 
Kourouma F, et al. Mastomys natalensis and Lassa fever, West  
Africa. Emerg Infect Dis. 2006;12:1971–4. http://dx.doi.org/ 
10.3201/eid1212.060812
Address for correspondence: Fabian H. Leendertz, Robert Koch Institut, 
Seestrasse 10, 13353 Berlin, Germany; email: leendertzf@rki.de
Rickettsia felis Infection 
among Humans, Bangladesh, 
2012–2013
Faria Ferdouse, Muhammad Akram Hossain, 
Shyamal Kumar Paul, Salma Ahmed,  
Md Chand Mahmud, Rajib Ahmed,  
A.K.M. Fazlul Haque, M. Nur-a-Alam Khan,  
Souvik Ghosh, Noriko Urushibara,  
Nobumichi Kobayashi
Author affiliations: Mymensingh Medical College, Mymensingh, 
Bangladesh (F. Ferdouse, M.A. Hossain, S.K. Paul, S. Ahmed, 
M.C. Mahmud, R. Ahmed, A.K.M.F. Haque, M.N.A. Khan);  
Sapporo Medical University School of Medicine, Sapporo, Japan 
(S. Ghosh, N. Urushibara, N. Kobayashi); Ross University School 
of Veterinary Medicine, St. Kitts, West Indies (S. Ghosh)
DOI: http://dx.doi.org/10.3201/eid2108.150328
To the Editor: Rickettsia felis, which belongs to the 
spotted fever group of rickettsiae, causes febrile illness in 
humans. The main vector of this bacterium is the cat flea 
(Ctenocephalides felis). Since publication of reports of R. 
felis as a putative pathogen of humans in the United States 
in 1994, R. felis infection in humans worldwide has been 
increasingly described, especially in the Americas, Europe, 
Africa, and eastern Asia (1,2). R. felis infection is common 
among febrile patients (≈15%) in tropical Africa (3) and 
among apparently healthy persons in eastern coastal prov-
inces of China (4). However, little is known about preva-
lence of R. felis infection of humans in southern Asia, al-
though 3 serologically diagnosed cases in Sri Lanka have 
been described (5) and R. felis has been detected in rodent 
fleas in Afghanistan (6). Hence, we conducted a cross-sec-
tional study in Bangladesh to explore the presence of rickett-
sial pathogens among patients with fever of unknown origin.
Study participants were 150 patients at Mymensingh 
Medical College (MMC) hospital in Mymensingh, north-
central Bangladesh, from July 2012 through January 2014, 
and 30 healthy control participants from the staff at the 
same college. Selected patients met the following criteria: 
1) fever (axillary temperature >37.5°C) for >15 days that 
did not respond to common antimicrobial drug therapy; 2) 
any additional clinical features including headache, rash, 
lymphadenopathy, myalgia, and eschars on skin; and 3) ti-
ter according to the Weil-Felix test (antibodies against any 
of 3 Proteus antigens) of >1:80. Patients with evident cause 
of fever (e.g., malaria diagnosed by blood smear or immu-
nochromatography) were excluded from the study. This 
research was approved by the college institutional review 
board, and informed consent was obtained from patients 
(or guardians) and healthy controls before their entry into 
the study.
Venous blood samples were aseptically collected 
from the patients, and DNA was extracted by conventional 
method by using proteinase K and sodium dodecyl sulfate. 
Nested PCR selective for the 17-kDa antigen gene was 
used to screen for rickettsiae according to the method de-
scribed previously (7); ≈100 ng of DNA in a 50-mL reac-
tion mixture was used. For each PCR, a negative control 
(water) was included and utmost care was taken to avoid 
contamination. Among the 150 samples tested, results were 
positive with a 232-bp amplified product for 69 (46%) and 
negative for all controls. 
PCR products from 20 samples were randomly select-
ed for sequence analysis. All nucleotide sequences from 
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